Kronos Bio, Inc. — Operating Income by Fiscal Year
7 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/99e7ee91-257f-4906-a50f-f2697c5facd6/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2024 | $-92.9M | 2024-01-01 – 2024-12-31 | evidence 0001741830-25-000009 |
| FY 2023 | $-122.1M | 2023-01-01 – 2023-12-31 | evidence 0001741830-25-000009 |
| FY 2022 | $-137.1M | 2022-01-01 – 2022-12-31 | evidence 0001741830-23-000011 |
| FY 2021 | $-151.4M | 2021-01-01 – 2021-12-31 | evidence 0001741830-22-000006 |
| FY 2020 | $-58.0M | 2020-01-01 – 2020-12-31 | evidence 0001741830-21-000018 |
| FY 2019 | $-16.8M | 2019-01-01 – 2019-12-31 | evidence 0001741830-21-000018 |
| FY 2018 | $-6.6M | 2018-01-01 – 2018-12-31 | evidence 0001741830-21-000018 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).